Co-Authors
This is a "connection" page, showing publications co-authored by Edoardo Savarino and Brigida Barberio.
Connection Strength
3.652
-
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? Gastroenterology. 2021 06; 160(7):2626-2627.
Score: 0.900
-
Medical and gastroenterological education during the COVID-19 outbreak. Nat Rev Gastroenterol Hepatol. 2020 08; 17(8):447-449.
Score: 0.895
-
The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem? Gastroenterology. 2021 04; 160(5):1903-1904.
Score: 0.893
-
Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak. J Clin Med. 2021 Jul 24; 10(15).
Score: 0.240
-
Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations. Dig Liver Dis. 2020 10; 52(10):1097-1098.
Score: 0.223
-
Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak. J Allergy Clin Immunol Pract. 2020 09; 8(8):2790-2792.e1.
Score: 0.222
-
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak. J Clin Med. 2020 Jun 26; 9(6).
Score: 0.222
-
Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study. J Med Internet Res. 2020 11 02; 22(11):e19574.
Score: 0.057